Covid 19 vaccine race – who’s in pole position?

A number of companies and research teams around the globe are struggling to develop a vaccine against the SARS-CoV-2 virus, which causes Covid-19. Billions and billions of dollars have been spent to develop a vaccine in the shortest possible time frame Certain media reports note that six coronavirus vaccines are the final stage of human trials – three from China, one from the UK (AZN/Oxford), and two from the U.S. (Pfizer/BioNTech and Moderna). Billions invested The Biomedical Advanced Research and Development Authority (BARDA) is pouring billions of dollars into pharmaceuticals and biotechnology companies like AstraZeneca (LON: AZN) to speed up